Cholesterol Drug Recalled Due To Side Effects: Doctors Told To Stop Prescribing Tredaptive
A cholesterol drug produced by pharmaceutical giant Merck is being recalled over concerns that it is ineffective and causing a host of serious side effects. The drug Tredaptive is supposed to raise HDL levels, the good cholesterol, but new trials show the cholesterol drug fails to work.
The cholesterol drug, which is sold in 40 countries but not the United States, failed to to lower the risk of heart attack and stroke, according to USA Today, and doctors have since been told to stop prescribing the cholesterol drug.
Like Us on Facebook
In addition to failing to work, the cholesterol drug also came with serious side effects, including blood and lymphatic, gastrointestinal, infections, metabolism, musculoskeletal, respiratory and skin issues, which are categorized as serious, but non-fatal.
Merck said it decided to recall its cholesterol drug due to a European Medicine Agency committee recommendation, according to the Chicago Tribune.
The cholesterol drug recall isn't expected to impact the company, however, as Tredaptive only makes up a small percentage of Merck's sales. During 2012, the cholesterol drug only posted $13 million in sales.
© 2012 iScience Times All rights reserved. Do not reproduce without permission.